5-Amino-1MQ 10mg
5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme linked to obesity and metabolic dysfunction. Research demonstrates that NNMT inhibition increases cellular NAD+ levels, activates SIRT1, and promotes energy expenditure. Animal studies show reduction in body weight and fat mass without changes in food intake.
Sequence
Small molecule NNMT inhibitor (non-peptide)
Market avg: $54.99 — save 42%
Volume pricing
Pay with USDC via Coinbase Commerce
Certificate of Analysis
Independently verified by Janoshik Analytical
Test ID
JAN-5A1MQ-2026-001
Purity
99.3%
Method
HPLC-MS
Batch
5A1MQ-2026-01A
Test Date
February 1, 2026
Identity
Confirmed
Storage Requirements
Lyophilized
Room temperature (15-25°C), protect from light
Reconstituted
2-8°C, use within 30 days
Small molecule, not a peptide. Very stable compound.
Published Research
2 peer-reviewed studies
NNMT: A new therapeutic target for metabolic syndrome
Kraus D, Yang Q, Kong D, et al. — Cell Metabolism, 2014
Discovery of NNMT as a metabolic regulator and target for obesity treatment.
Antisense oligonucleotide-mediated knockdown of NNMT reduces body weight in diet-induced obese mice
Neelakantan H, Vance V, Wetzel MD, et al. — Journal of Pharmacology and Experimental Therapeutics, 2018
Study showing NNMT inhibition reduces obesity in diet-induced obese models.
Related Products
Research use only. All products are sold strictly for in-vitro research purposes only. Not for human consumption. Information provided references published research literature. No medical claims are made or implied.